Date of Completion


Document Type


Degree Name

Bachelor of Science in Medical Laboratory Science


DS-TB, tuberculosis, drug-susceptible tuberculosis, tuberculosis in COVID-19 pandemic, tuberculosis treatment, tuberculosis treatment management, COVID-19, tuberculosis treatment initiation, tuberculosis treatment outcomes, drug-susceptible, Tagaytay City, diagnosis, treatment, impact


Tuberculosis (TB) is a bacterial infection caused by Mycobacterium tuberculosis complex (MTBC) which mainly infects the lungs. In 2019, there was an estimated 10 million TB cases worldwide, wherein 1.4 million died. The Philippines has ranked 4th globally with the highest cases of TB (WHO, 2020). However, by 2020, because of the COVID-19 pandemic, the number of cases reportedly declined nationwide (DOH, 2020). Due to the restrictions posed by the pandemic, the researchers hypothesized that there might also be a significant difference in the treatment management of DS-TB patients before and during the pandemic because of their consistent need to have access to the medicine. Through the use of a cross-sectional research design, the researchers looked into the Tagaytay CHO DS-TB data registry to study the treatment management of 272 drugsusceptible tuberculosis (DS-TB) patients enrolled pre-pandemic and 111 DS-TB patients enrolled during the pandemic. This study had found that there is no significant difference in the proportions between the treatment management of DS-TB patients from pre-pandemic and during the pandemic. The DS-TB treatment initiation rate in the Tagaytay CHO remained at 100% during the COVID-19 pandemic, while DS-TB treatment outcome rate was found to be successful at 99.3% and 97.3% before and during the pandemic, respectively. This suggests that the Tagaytay CHO was able to carry on with their services in managing the treatment of their patients despite the problems posed by the pandemic.

First Advisor

Carolina Capili